Filing Details

Accession Number:
0000711377-16-000084
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-03 18:02:53
Reporting Period:
2016-09-29
Filing Date:
2016-10-03
Accepted Time:
2016-10-03 18:02:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1517426 J. Steven Quinlan 620 Lesher Place
Lansing MI 48912
Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-09-29 3,000 $23.07 13,103 No 4 M Direct
Common Stock Disposition 2016-09-30 3,000 $55.15 10,103 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2016-09-29 3,000 $0.00 3,000 $23.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
67,750 2016-09-29 No 4 M Direct
Footnotes
  1. Options were granted on 9/29/2011, have five year lives, and vest in equal annual installments on each of the five anniversary dates of the grant